170 related articles for article (PubMed ID: 37566212)
1. Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study.
Egger M; Salmanton-García J; Barac A; Gangneux JP; Guegan H; Arsic-Arsenijevic V; Matos T; Tomazin R; Klimko N; Bassetti M; Hammarström H; Meijer EFJ; Meis JF; Prattes J; Krause R; Resat Sipahi O; Scharmann U; White PL; Desoubeaux G; García-Rodríguez J; Garcia-Vidal C; Martín-Pérez S; Ruiz M; Tumbarello M; Talento AF; Rogers B; Lagrou K; van Praet J; Arikan-Akdagli S; Arendrup MC; Koehler P; Cornely OA; Hoenigl M;
Mycopathologia; 2023 Dec; 188(6):983-994. PubMed ID: 37566212
[TBL] [Abstract][Full Text] [Related]
2. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.
Hoenigl M; Salmanton-García J; Egger M; Gangneux JP; Bicanic T; Arikan-Akdagli S; Alastruey-Izquierdo A; Klimko N; Barac A; Özenci V; Meijer EFJ; Khanna N; Bassetti M; Rautemaa-Richardson R; Lagrou K; Adam KM; Akalin EH; Akova M; Arsic Arsenijevic V; Aujayeb A; Blennow O; Bretagne S; Danion F; Denis B; de Jonge NA; Desoubeaux G; Drgona L; Erben N; Gori A; García Rodríguez J; Garcia-Vidal C; Giacobbe DR; Goodman AL; Hamal P; Hammarström H; Toscano C; Lanternier F; Lass-Flörl C; Lockhart DEA; Longval T; Loughlin L; Matos T; Mikulska M; Narayanan M; Martín-Pérez S; Prattes J; Rogers B; Rahimli L; Ruiz M; Roilides E; Samarkos M; Scharmann U; Sili U; Sipahi OR; Sivakova A; Steinmann J; Trauth J; Turhan O; Van Praet J; Vena A; White PL; Willinger B; Tortorano AM; Arendrup MC; Koehler P; Cornely OA;
Lancet Infect Dis; 2023 Jun; 23(6):751-761. PubMed ID: 37254300
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
[TBL] [Abstract][Full Text] [Related]
5. Six-Year Retrospective Analysis of Epidemiology, Risk Factors, and Antifungal Susceptibilities of Candidiasis from a Tertiary Care Hospital in South China.
Bilal H; Zhang D; Shafiq M; Khan MN; Chen C; Khan S; Wang Q; Cai L; Islam R; Hu H; Zeng Y
Microbiol Spectr; 2023 Aug; 11(4):e0070823. PubMed ID: 37310269
[TBL] [Abstract][Full Text] [Related]
6. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Doğan Ö; Yeşilkaya A; Menekşe Ş; Güler Ö; Karakoç Ç; Çınar G; Kapmaz M; Aydın M; Keske Ş; Şahin S; Hacıseyitoğlu D; Yalçın D; Tekin S; Ataç N; Albayrak Ö; Aksu ED; Can F; Ergönül Ö
Int J Antimicrob Agents; 2020 Jul; 56(1):105992. PubMed ID: 32335275
[TBL] [Abstract][Full Text] [Related]
7. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of candidemia in children at a university hospital: A retrospective cohort.
Guner Ozenen G; Sahbudak Bal Z; Avcu G; Ozkaya Yazici P; Karakoyun M; Metin DY; Hilmioglu Polat S
Mycoses; 2023 May; 66(5):367-377. PubMed ID: 36597951
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcomes of candidemia caused by Candida parapsilosis complex in a medical center in northern Taiwan.
Wu YM; Huang PY; Lu JJ; Shie SS; Ye JJ; Wu TS; Huang CT
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):44-49. PubMed ID: 29132935
[TBL] [Abstract][Full Text] [Related]
10. Initial antifungal strategy does not correlate with mortality in patients with candidemia.
Murri R; Scoppettuolo G; Ventura G; Fabbiani M; Giovannenze F; Taccari F; Milozzi E; Posteraro B; Sanguinetti M; Cauda R; Fantoni M
Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):187-93. PubMed ID: 26634352
[TBL] [Abstract][Full Text] [Related]
11. Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.
Kontoyiannis DP; Bassetti M; Nucci M; Capparella MR; Yan JL; Aram J; Hogan PA
Mycoses; 2017 Oct; 60(10):663-667. PubMed ID: 28597967
[TBL] [Abstract][Full Text] [Related]
12. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
Megri Y; Arastehfar A; Boekhout T; Daneshnia F; Hörtnagl C; Sartori B; Hafez A; Pan W; Lass-Flörl C; Hamrioui B
Antimicrob Resist Infect Control; 2020 Apr; 9(1):50. PubMed ID: 32264966
[TBL] [Abstract][Full Text] [Related]
13. Candidemia in children.
Zaoutis T
Curr Med Res Opin; 2010 Jul; 26(7):1761-8. PubMed ID: 20513207
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study.
Li Y; Gu C; Yang Y; Ding Y; Ye C; Tang M; Liu J; Zeng Z
BMC Infect Dis; 2023 Jun; 23(1):369. PubMed ID: 37264301
[TBL] [Abstract][Full Text] [Related]
16. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
17. Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010-2019: A retrospective observational study based on national surveillance data.
Kajihara T; Yahara K; Nagi M; Kitamura N; Hirabayashi A; Hosaka Y; Abe M; Miyazaki Y; Sugai M
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36095139
[TBL] [Abstract][Full Text] [Related]
18. Comparison of risk factors and outcomes of Candida auris candidemia with non-Candida auris candidemia: A retrospective study from Pakistan.
Sayeed MA; Farooqi J; Jabeen K; Mahmood SF
Med Mycol; 2020 Aug; 58(6):721-729. PubMed ID: 31773169
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of PNA-FISH method for direct identification of Candida species in blood culture samples and its potential impact on guidance of antifungal therapy].
Doğan Ö; İnkaya AÇ; Gülmez D; Uzun Ö; Akova M; Arıkan Akdağlı S
Mikrobiyol Bul; 2016 Oct; 50(4):580-589. PubMed ID: 28124963
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014.
Liu WL; Lai CC; Li MC; Wu CJ; Ko WC; Hung YL; Tang HJ; Hsueh PR
J Microbiol Immunol Infect; 2019 Aug; 52(4):612-619. PubMed ID: 28886952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
